Earnings Highlights from Cardinal Health’s (CAH) Q4 2024 Financial Results
Overview of Cardinal Health's Q4 2024 Results
Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, has reported impressive financial results for the fourth quarter of 2024. The company achieved a revenue increase of 12% year-over-year, reaching $59.9 billion.
Segment Performance
- Pharmaceutical and Specialty Solutions segment revenue rose by 13% to $55.6 billion.
- The Global Medical Products and Distribution segment grew by 2%, totaling $3.1 billion.
Financial Highlights
- Operating earnings exceeded expectations, more than tripling to $401 million.
- Net income for Q4 was $235 million, equating to $0.96 per share.
- Adjusted earnings per share rose 29% to $1.84.
In the full fiscal year, Cardinal Health also reported record-high operating cash flow of $3.8 billion and adjusted free cash flow of $3.9 billion.
Future Guidance
The company has raised its adjusted EPS guidance for fiscal 2025 to a range of $7.55-$7.70, up from at least $7.50, reflecting strong confidence in ongoing performance.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.